Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
In the SURPASS clinical trials for type 2 diabetes, patients achieved A1c reductions ranging from 1.9% to 2.4% at the highest doses by week 40
References: These statements have not been evaluated by the Food and Drug Administration (FDA)
The term GLP-1 is a total buzzword right now, with many people taking medications like GLP-1 agonists or receptor agonists, or looking to increase their GLP-1 naturally
It might be possible to reduce food consumption if you can feel satisfied for longer periods
Common side effects Nausea (the most common one across both) Constipation Diarrhoea Fatigue (in early weeks) Vomiting (Commonly during dose increases) Most are gastrointestinal, mild to moderate, and improve significantly after the dose escalation phase
US$ 22.82
US$ 24.72
US$ 29.13
